Good health is positively or negatively influenced by dietary habits & choices. In the current scenario, healthy fibre-rich plant-based food choices are replaced by high-fat sugary, animal fat-loaded & salty food cravings. Cumulatively this ongoing lifestyle disbalance is inviting life-threatening non-communicable diseases like obesity, type 2 diabetes mellitus, cardiovascular diseases & cancer.
Maintaining ideal body weight & losing extra weight is gaining popularity among the health-conscious population. Sugar consumption plays an important role in every weight-related journey. Sugar appetite is getting replaced by artificial sweeteners (AS).
The efficacy, safety & advantages of AS are not fully established & controversial. This needs a clear understanding of whether a high intake of AS is harmful or useful for diabetics.
The distinct structure of AS makes their metabolism, digestion & fermentation different. This has raised concerns towards the unmetabolized compounds in non-communicable disease development.
Acesulfame Potassium
Shows fast absorption, does not reach the low gastrointestinal tract & not impact intestinal microbiota. Mainly excreted through urine & faeces.
Saccharin
Partially excreted through urine & faeces. Small parts do not get absorbed immediately & affect intestinal microbiota.
Aspartame
Rapidly digested & not affecting intestinal microbiota.
Sucralose
Maximum part eliminated through faeces & urine. Affects gut microbiota through bacteriostatic effects.
Steviol Glycoside
Depicts slow metabolization & excretion through urine.
Body weight & adiposity
Energy balance gets affected by AS, thus the body weight. This process is different from natural sugar metabolism which acts through physiological processes comprising the gut microbiota, the reward system and adipogenesis.
AS interacts with the taste 1 receptor (T1R) family of sweet-taste receptors in the oral cavity and gastrointestinal tract, leading to changes in satiety, energy intake, adipogenesis & body weight. Simultaneously AS causes variation in intestinal bacterial balance by increasing short-chain fatty acid (SCFA) production. This brings enhancement in lipid oxidation, energy expenditure & disturbance in gut-brain signalling.
Gut microbiota
AS increases intestinal dysbiosis & changes the microbial composition and Bacteroidetes ratio.
Glucose homeostasis
After AS intake SGLT1 (sodium-glucose transporter 1) and GLUT2 (glucose transporter 2) get upregulated leading to an increase in intestinal glucose absorption. Also AS interacts with GPCR (G-protein coupled receptor) & affects insulin secretory capacity. AS-induced intestinal dysbiosis provokes SCFA production & affects insulin secretion. Concurrently LPS (lipopolysaccharide) levels increase, chronic inflammation & endotoxemia occur, fat accumulates & insulin resistance-mediated diabetes is established.
For healthy outcomes and good quality of life, adequate nutrition & positive lifestyle habits are required & not unnecessarily AS ingestion. Uncontrolled intake of AS & processed food made out of it is a threat to good health with an increased risk of chronic lifestyle diseases.
High AS usage is not a remedy to control diabetes but may alter insulin sensitivity & enhance proneness towards diabetes. AS usage should be minimized & future research is essential to understand the evidence about the safety & true benefits of AS in diabetes.
1.
Long Wait Times on the Other Side of the Pond: King Charles' Cancer Diagnosis.
2.
recognizing the mechanism by which the replication of the host cell is outperformed by the skin cancer virus.
3.
FINAL USPSTF RECOMMENDATIONS ON ANXIETY, DEPRESSION, AND SUIICIDAL RISK.
4.
Durvalumab Wins FDA Approval in Limited-Stage SCLC
5.
Telehealth in the pandemic era resulted in fewer therapy interruptions.
1.
Multidisciplinary Insights into Diagnosis, Management, and Outcomes in Oncology
2.
CAR T + Ibrutinib in R/R Mantle Cell Lymphoma: Phase 2 TARMAC Study Insights
3.
Personalized Cancer Vaccines: The Next Frontier in Precision Oncology
4.
AI Meets the Gut Microbiome: Early Detection of GI Malignancies Redefined
5.
How Parvovirus B19 Affects Pregnant Women and Their Unborn Babies
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V
2.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management
3.
Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care
4.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
5.
Navigating the Complexities of Ph Negative ALL - Part XI
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation